Skip to content

Diagnostics
Biopharma
Platform
About us
- Who we are
- Science
- Press
News
Contact & demo
Login

Diagnostics
Biopharma
Platform
About us
- Who we are
- Science
- Press
News
Contact & demo
Login

Archives: Hot news

New HRD genetic test

Michael Blum is SeqOne’s new Head of Research and Development

SeqOne Genomics announces Portuguese distribution partnership

Unicancer and SeqOne collaborate on genomic knowledge sharing

SeqOne closes €20M series A to accelerate deployment of its genomic medicine platform

Auragen chooses SeqOne for genomic interpretation

Search for:

Recent Posts

SeqOne at ESHG 2023: A.I. for Diagnostics
SeqOne’s new clinically validated HRD test reduces the number of inconclusive results to improve the prescription of targeted treatments for ovarian cancer patients
SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times
Michael Blum joins SeqOne Genomics to head the company’s Research and Development
SeqOne Genomics announces Portuguese distribution partnership

Recent Comments

AffiliateLabz on EUROFINS BIOMNIS AND SEQONE PARTNER TO IMPROVE CLINICAL ACCESS TO WHOLE EXOME TESTING
ExoRank.com on EUROFINS BIOMNIS AND SEQONE PARTNER TO IMPROVE CLINICAL ACCESS TO WHOLE EXOME TESTING

Stay in the loop

Get notified of SeqOne new annoucements.

Email Address*

Your e-mail address will be used to send you our newsletter. Learn more about our privacy policy.

Next generation genomics for next generation healthcare.

© SeqOne 2023 – All rights reserved.

Menu

Home
Platform
Science
About us
News
Contact & demo
Platform login
Privacy & cookie policy
Cookie settings

Solutions for

Diagnostics
Biopharma

Applications

Rare and hereditary diseases
Hereditary cancer predisposition
Somatic cancers

Contact us

+33 (0)9 54 40 42 84
contact@seqone.com

SeqOne S.A.S.
22 rue Durand
34000 Montpellier,
France

Diagnostics
Biopharma
Platform
About us
- Who we are
- Science
- Press
News
Contact & demo
Login